☆ 4.6 Article

Theranostic Robot-Assisted Radical Prostatectomy: Things Understood and Not Understood

CANCERS (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Andrology

Improving the understanding of PI-RADS in practice: characters of PI-RADS 4 and 5 lesions with negative biopsy

Yu-Hao Wang et al.

Summary: This study summarized the MRI characteristics of patients with prostate lesions assessed as PI-RADS 4 and 5 but had negative biopsy results. The main reasons for false-positive MRI diagnosis were PI-RADS overestimation, ambiguous images giving higher PI-RADS, diseases that were really difficult to distinguish, and missed lesion in the initial biopsy.

ASIAN JOURNAL OF ANDROLOGY (2023)

添加到收藏夹

Article Oncology

Deferred radical prostatectomy in patients who initially elected for active surveillance: a multi-institutional, prospective, observational cohort of the PRIAS-JAPAN study

Yoichiro Tohi et al.

Summary: In the short-term follow-up, radical prostatectomy after active surveillance does not result in loss of curative chances for Japanese patients with early-stage prostate cancer. The 3-year prostate-specific antigen recurrence-free survival rate was 96.9%.

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2022)

添加到收藏夹

Editorial Material Urology & Nephrology

Active Surveillance for Low-Risk Prostate Cancer: The Uphill Battles and the Unnecessary Ones

Kenneth Chen et al.

JOURNAL OF UROLOGY (2022)

添加到收藏夹

Editorial Material Urology & Nephrology

TRUS Biopsy vs Transperineal Biopsy for Suspicion of Prostate Cancer

Peter K. F. Chiu et al.

UROLOGY (2022)

添加到收藏夹

Article Urology & Nephrology

Active surveillance for intermediate-risk prostate cancer

Madhur Nayan et al.

Summary: While active surveillance (AS) is established for low-risk prostate cancer, its safety for intermediate-risk (IR) disease remains uncertain. Lack of randomized trials and limitations of observational studies call for further research to identify which IR prostate cancer patients can be safely managed with AS.

WORLD JOURNAL OF UROLOGY (2022)

添加到收藏夹

Article Oncology

Prostate Cancer Characteristics and Outcomes after Prostatectomy in Asian-American Men

Tanya Dorff et al.

Summary: Chinese-American men have better survival rates after hormone therapy compared to men of other Asian backgrounds. There are differences in prostate cancer characteristics among different Asian groups. Future research should categorize Asian men by subgroup to better understand the observed differences.

CLINICAL GENITOURINARY CANCER (2022)

添加到收藏夹

Article Urology & Nephrology

Functional and quality of life outcomes of localised prostate cancer treatments (Prostate Testing for Cancer and Treatment [ProtecT] study)

Janet Athene Lane et al.

Summary: This study investigates the functional and quality of life outcomes of treatments for localized prostate cancer and provides valuable information for treatment decision-making. The findings show that men receiving active monitoring treatment experience gradual declines in sexual and urinary function with age, while radical treatments have immediate and continued impacts over 6 years. Furthermore, men treated with external-beam radiation therapy (EBRT) experience worse bowel function and bother compared to other treatments.

BJU INTERNATIONAL (2022)

添加到收藏夹

Review Oncology

Different Nerve-Sparing Techniques during Radical Prostatectomy and Their Impact on Functional Outcomes

Iason Kyriazis et al.

Summary: This literature review summarizes the different nerve-sparing techniques applied during radical prostatectomy, highlighting that nerve-sparing is a field under constant development. Despite various techniques and categorizations, further research is needed to determine the best nerve-sparing technique.

CANCERS (2022)

添加到收藏夹

Article Medicine, General & Internal

Incidental Prostate Cancer from Prostate with Benign Biopsies: A Predictive and Survival Analysis from Cohort Study

Che Hsueh Yang et al.

Summary: This study focused on incidental prostate cancer from preoperative benign biopsies and found that PSA was the strongest predictor. The research compared survival outcomes under different managements and concluded that RASP and RARP had similar effects in the short term.

INTERNATIONAL JOURNAL OF GENERAL MEDICINE (2022)

添加到收藏夹

Article Surgery

Is PSA Still the Best Predictor for Biochemical Recurrence after Radical Prostatectomy in High-Risk Prostate Cancer?

Serkan Akan et al.

Summary: This study assessed the effects of D'Amico criteria on biochemical recurrence (BCR) after RP in patients with high-risk prostate cancer. The results showed significant differences in BCR rates among different groups based on the criteria. Elevated tPSA level remained an important predictor for BCR-free survival.

JOURNAL OF INVESTIGATIVE SURGERY (2022)

添加到收藏夹

Article Pathology

Gleason Score Evolution and the Effect on Prostate Cancer Outcomes

Gregory P. Swanson et al.

Summary: The study evaluated the impact of changes in Gleason grading on the long-term outcomes of prostatectomy patients, showing that revised Gleason scores improved outcomes in all risk groups, with a consistent increase in risk of biochemical failure, metastatic disease, and prostate cancer-related death with each successive grade.

AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2021)

添加到收藏夹

Article Oncology

Prostate Cancer, Version 1.2021 Featured Updates to the NCCN Guidelines

Edward Schaeffer et al.

Summary: The NCCN Guidelines for Prostate Cancer provide recommendations for staging and risk assessment post-diagnosis, with management options for localized, regional, and metastatic disease. The guidelines also cover disease monitoring and treatment of recurrent disease. The NCCN Prostate Cancer Panel meets annually to update recommendations based on new clinical data, aiming to provide the most effective care for patients.

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2021)

添加到收藏夹

Article Oncology

Comparison of Multiparametric Magnetic Resonance Imaging-Targeted Biopsy With Systematic Transrectal Ultrasonography Biopsy for Biopsy-Naive Men at Risk for Prostate Cancer A Phase 3 Randomized Clinical Trial

Laurence Klotz et al.

Summary: In men at risk for prostate cancer, magnetic resonance imaging followed by selected targeted biopsy is noninferior to initial systematic biopsy in detecting grade group 2 or greater cancers.

JAMA ONCOLOGY (2021)

添加到收藏夹

Article Medicine, General & Internal

Biochemical recurrence of pathological T2+localized prostate cancer after robotic-assisted radical prostatectomy: A 10-year surveillance

Che Hseuh Yang et al.

Summary: Long-term surveillance of pT2+ prostate cancer patients revealed that robotic-assisted RP can offer better BCR-free survival in more severe cases, and routine aRT is not recommended for this type of prostate cancer.

WORLD JOURNAL OF CLINICAL CASES (2021)

添加到收藏夹

Review Oncology

PSMA Theranostics: Current Landscape and Future Outlook

Hanbo Zhang et al.

Summary: The prognosis for metastatic prostate cancer patients remains poor, but PSMA-targeted imaging and therapy show promise as a potential standard of care. PSMA is a novel molecular target that may alter the natural history of prostate cancer, with a growing body of evidence supporting its use in theranostic approaches.

CANCERS (2021)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Long-Term Follow-up and Outcomes of Retreatment in an Expanded 50-Patient Single-Center Phase II Prospective Trial of 177Lu-PSMA-617 Theranostics in Metastatic Castration-Resistant Prostate Cancer

John Violet et al.

JOURNAL OF NUCLEAR MEDICINE (2020)

添加到收藏夹

Review Oncology

Lutetium-177 prostate-specific membrane antigen (PSMA) theranostics: practical nuances and intricacies

Amir Iravani et al.

PROSTATE CANCER AND PROSTATIC DISEASES (2020)

添加到收藏夹

Article Urology & Nephrology

Active Surveillance of Grade Group 1 Prostate Cancer: Long-term Outcomes from a Large Prospective Cohort

Jeffrey J. Tosoian et al.

EUROPEAN UROLOGY (2020)

添加到收藏夹

Article Oncology

Building a Nomogram for Prediction of Prostate Cancer in Patients With Preoperatively Suspected Prostate Cancer

Yen Chuan Ou et al.

ANTICANCER RESEARCH (2020)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Is the Vision of Radioligand Therapy for Prostate Cancer Becoming a Reality? An Overview of the Phase III VISION Trial and Its Importance for the Future of Theranostics

Kambiz Rahbar et al.

JOURNAL OF NUCLEAR MEDICINE (2019)

添加到收藏夹

Article Oncology

[177Lu]-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial): a single-centre, single-arm, phase 2 study

Michael S. Hofman et al.

LANCET ONCOLOGY (2018)

添加到收藏夹

Editorial Material Urology & Nephrology

Towards an individualized approach for predicting post-prostatectomy urinary incontinence: the role of nerve preservation and urethral stump length

Henk G. van der Poel et al.

BJU INTERNATIONAL (2018)

添加到收藏夹

Article Oncology

Prophylactic Robotic-assisted Laparoscopic Radical Prostatectomy for Preoperative Suspicion of Prostate Cancer: Experience with 55 Cases

Yen-Chuan Ou et al.

ANTICANCER RESEARCH (2016)

添加到收藏夹

Editorial Material Urology & Nephrology

Synopsis of the PI-RADS v2 Guidelines for Multiparametric Prostate Magnetic Resonance Imaging and Recommendations for Use

Jelle O. Barentsz et al.

EUROPEAN UROLOGY (2016)

添加到收藏夹

Article Urology & Nephrology

PI-RADS Prostate Imaging - Reporting and Data System: 2015, Version 2

Jeffrey C. Weinreb et al.

EUROPEAN UROLOGY (2016)

添加到收藏夹

Review Oncology

Prostate MRI based on PI-RADS version 2: how we review and report

Philipp Steiger et al.

CANCER IMAGING (2016)

添加到收藏夹

Article Urology & Nephrology

EAU Guidelines on Prostate Cancer. Part II: Treatment of Advanced, Relapsing, and Castration-Resistant Prostate Cancer

Axel Heidenreich et al.

EUROPEAN UROLOGY (2014)

添加到收藏夹

Article Oncology

Risk of Biochemical Recurrence and Positive Surgical Margins in Patients With pT2 Prostate Cancer Undergoing Radical Prostatectomy

Martin Andreas Roder et al.

JOURNAL OF SURGICAL ONCOLOGY (2014)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.